Curt Wolfgang

Curt Wolfgang has extensive experience in the pharmaceutical industry. Curt currently holds the position of Executive Director of Global Development Strategy at BioCryst Pharmaceuticals, Inc. Prior to this, Curt served as the Vice President of Clinical Development at Clovis Oncology. Curt also held senior positions at G1 Therapeutics, Inc., Rho, GlycoMimetics, Vanda Pharmaceuticals, and Novartis. Curt began their career as a Postdoctoral Fellow at the National Cancer Institute. Throughout their career, they have been responsible for leading and overseeing various aspects of clinical development and research projects.

Curt Wolfgang received a Bachelor of Science degree in Biochemistry from Penn State University from 1989 to 1992. Subsequently, they pursued their Ph.D. in Biochemistry at The Ohio State University, where they completed their studies from 1992 to 1999.